This site demonstrates one possible use of this domain. For acquisition, partnership, or investment inquiries, please use our contact link.
Ketalux
Conditions

Ketamine for OCD

An honest look at where ketamine sits — and does not sit — in the current evidence base for obsessive-compulsive disorder.

Medically reviewed by: Pending medical review(draft)Last updated: May 18, 2026Evidence: Clinical overview

Condition overview

Obsessive-compulsive disorder (OCD) involves intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) used to reduce distress. OCD is treatable but often underrecognized and undertreated, and average time to effective care is unfortunately long.

Current standard treatments

  • Exposure and Response Prevention (ERP) — the gold standard
  • SSRIs, often at higher doses than for depression
  • Clomipramine in selected cases
  • Antipsychotic augmentation in resistant cases under specialist care
  • Intensive outpatient and residential ERP for severe or refractory cases

How ketamine might act on OCD

OCD research has implicated abnormalities in glutamate signaling within cortico-striatal circuits. Glutamate-modulating agents — including ketamine, memantine, and riluzole — have been explored on that basis. Evidence remains preliminary, and a clear pathway from mechanism to durable symptom relief has not been established.

Where ketamine may fit

A small number of studies have explored ketamine in OCD with mixed results. It is not established as a standard treatment, and people considering it should weigh the limited evidence carefully and ensure access to skilled OCD-specialist care, especially ERP.

Risks and limitations

Standard ketamine risks apply. The most important limitation here is the evidence base itself: it is not strong enough to recommend ketamine over established OCD treatments, and short-lived effects without a clear path to maintenance are a real concern. See safety & eligibility.

Who is not a candidate

  • Uncontrolled cardiovascular disease
  • Active psychosis or untreated bipolar mania
  • Active substance use disorders
  • Pregnancy
  • People who have not yet had access to adequate trials of ERP and SSRIs

Frequently asked questions

Is ketamine a treatment for OCD?+

Ketamine is not approved for OCD, and the evidence base is limited and mixed. Exposure and Response Prevention (ERP) remains the best-supported treatment.

What is the strongest treatment for OCD?+

Exposure and Response Prevention (ERP), a specialized form of CBT, has the strongest evidence. SSRIs — often at higher doses than for depression — are commonly used and well supported.

What do small ketamine studies suggest?+

Some small studies report modest, short-term symptom reductions; others do not. Findings are inconsistent, sample sizes are small, and durability beyond a few days is unclear.

Why is OCD harder to treat with rapid agents?+

OCD often involves entrenched thought-behavior loops shaped over years. Rapid pharmacologic shifts rarely retrain those patterns on their own. ERP works precisely because it changes behavior and learning over time.

Could ketamine make obsessions worse?+

There are anecdotal reports of intrusive thoughts feeling more vivid during or after sessions for some patients. Careful screening and a trusted OCD specialist matter.

Is ketamine useful for OCD with depression?+

When OCD co-occurs with treatment-resistant depression, the depression component may improve with ketamine more reliably than the OCD component. This should be considered in any treatment plan.

How long do effects last in OCD trials?+

Most reported effects in small OCD trials are short-lived — often days, not weeks. There is no well-established maintenance protocol for OCD specifically.

What about glutamate-targeting medications more broadly?+

OCD research has explored several glutamate-modulating agents (such as memantine and riluzole) as augmentation strategies. Evidence is mixed and these are not first-line treatments.

Where should someone start if they have OCD?+

An OCD-specialist clinician for ERP, often combined with an SSRI titrated to an adequate dose for a sufficient duration. Specialty programs exist for severe or refractory cases.

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.